These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 10800169)
1. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species. Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169 [TBL] [Abstract][Full Text] [Related]
2. von Willebrand factor contained in a high purity FVIII concentrate (Fanhdi) binds to platelet glycoproteins and supports platelet adhesion to subendothelium under flow conditions. Rivera J; Escolar G; Casamiquela R; Bravo MI; Jorquera JI; Castillo R; Ordinas A; Vicente V Haematologica; 1999 Jan; 84(1):5-11. PubMed ID: 10091386 [TBL] [Abstract][Full Text] [Related]
3. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor. Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543 [TBL] [Abstract][Full Text] [Related]
4. Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib. Girma JP; Takahashi Y; Yoshioka A; Diaz J; Meyer D Thromb Haemost; 1990 Oct; 64(2):326-32. PubMed ID: 1702906 [TBL] [Abstract][Full Text] [Related]
5. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib. Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886 [TBL] [Abstract][Full Text] [Related]
6. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727 [TBL] [Abstract][Full Text] [Related]
7. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin. Miura S; Nishida S; Makita K; Sakurai Y; Shimoyama T; Sugimoto M; Yoshioka A; Ishii K; Kito M; Kobayashi T; Fujimura Y Anal Biochem; 1996 May; 236(2):215-20. PubMed ID: 8660497 [TBL] [Abstract][Full Text] [Related]
8. Thrombin facilitates primary platelet adhesion onto vascular surfaces in the absence of plasma adhesive proteins: studies under flow conditions. Díaz-Ricart M; Estebanell E; Lozano M; Aznar-Salatti J; White JG; Ordinas A; Escolar G Haematologica; 2000 Mar; 85(3):280-8. PubMed ID: 10702817 [TBL] [Abstract][Full Text] [Related]
9. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked. Iijima K; Murata M; Nakamura K; Kitaguchi T; Handa M; Watanabe K; Fujimura Y; Yoshioka A; Ikeda Y Biochem Biophys Res Commun; 1997 Apr; 233(3):796-800. PubMed ID: 9168936 [TBL] [Abstract][Full Text] [Related]
10. Characterization of murine anti-glycoprotein Ib monoclonal antibodies that differentiate between shear-induced and ristocetin/botrocetin-induced glycoprotein Ib-von Willebrand factor interaction. Cauwenberghs N; Ajzenberg N; Vauterin S; Hoylaerts MF; Declerck PJ; Baruch D; Deckmyn H Haemostasis; 2000; 30(3):139-48. PubMed ID: 11014964 [TBL] [Abstract][Full Text] [Related]
11. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor. Kasirer-Friede A; Frojmovic MM Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623 [TBL] [Abstract][Full Text] [Related]
12. How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects? Xu G; Ulrichts H; Vauterin S; De Meyer SF; Deckmyn H; Teng M; Niu L Toxicon; 2005 Apr; 45(5):561-70. PubMed ID: 15777951 [TBL] [Abstract][Full Text] [Related]
13. Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex. Graham SS; Gonchoroff NJ; Miller JL Am J Clin Pathol; 2001 Jan; 115(1):144-7. PubMed ID: 11190800 [TBL] [Abstract][Full Text] [Related]
14. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis. Azzam K; Cissé-Thiam M; Drouet L Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802 [TBL] [Abstract][Full Text] [Related]
16. Fine structural and functional consequences of deglycosylation of the platelet adhesion receptor GPIb-IX (CD 42b). Moshfegh K; Lengweiler S; Häner M; Aebi U; Steiner B; Beer JH Biochem Biophys Res Commun; 1998 Aug; 249(3):903-9. PubMed ID: 9731234 [TBL] [Abstract][Full Text] [Related]
17. Evidence from limited proteolysis of a ristocetin-induced conformational change in human von Willebrand factor that promotes its binding to platelet glycoprotein Ib-IX-V. Kang M; Wilson L; Kermode JC Blood Cells Mol Dis; 2008; 40(3):433-43. PubMed ID: 17977030 [TBL] [Abstract][Full Text] [Related]
18. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib. Fujimura Y; Ikeda Y; Miura S; Yoshida E; Shima H; Nishida S; Suzuki M; Titani K; Taniuchi Y; Kawasaki T Thromb Haemost; 1995 Aug; 74(2):743-50. PubMed ID: 8585016 [TBL] [Abstract][Full Text] [Related]
19. Mapping and functional studies of two alloantibodies developed in patients with type 3 von Willebrand disease. Tout H; Obert B; Houllier A; Fressinaud E; Rothschild C; Meyer D; Girma JP Thromb Haemost; 2000 Feb; 83(2):274-81. PubMed ID: 10739386 [TBL] [Abstract][Full Text] [Related]
20. Asialo von Willebrand factor enhances platelet adhesion to vessel subendothelium. Bastida E; Monteagudo J; Ordinas A; De Marco L; Castillo R Thromb Haemost; 1988 Aug; 60(1):30-4. PubMed ID: 3263711 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]